These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genetic, developmental, and physical factors associated with attention deficit hyperactivity disorder in patients with velocardiofacial syndrome. Gothelf D, Presburger G, Levy D, Nahmani A, Burg M, Berant M, Blieden LC, Finkelstein Y, Frisch A, Apter A, Weizman A. Am J Med Genet B Neuropsychiatr Genet; 2004 Apr 01; 126B(1):116-21. PubMed ID: 15048660 [Abstract] [Full Text] [Related]
4. Otolaryngological manifestations of velocardiofacial syndrome: a retrospective review of 35 patients. Ford LC, Sulprizio SL, Rasgon BM. Laryngoscope; 2000 Mar 01; 110(3 Pt 1):362-7. PubMed ID: 10718420 [Abstract] [Full Text] [Related]
6. Clinical correlation of chromosome 22q11.2 fluorescent in situ hybridization analysis and velocardiofacial syndrome. Oh AK, Workman LA, Wong GB. Cleft Palate Craniofac J; 2007 Jan 01; 44(1):62-6. PubMed ID: 17214538 [Abstract] [Full Text] [Related]
7. Videonasopharyngoscopy in patients with 22q11.2 deletion syndrome (Shprintzen syndrome). Ysunza A, Pamplona MC, Ramírez E, Canún S, Sierra MC, Silva-Rojas A. Int J Pediatr Otorhinolaryngol; 2003 Aug 01; 67(8):911-5. PubMed ID: 12880672 [Abstract] [Full Text] [Related]
8. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects. Hou JW, Wang JK, Tsai WY, Chou CC, Wang TR. J Formos Med Assoc; 1997 Jun 01; 96(6):419-23. PubMed ID: 9216164 [Abstract] [Full Text] [Related]
12. Clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience. Vantrappen G, Rommel N, Devriendt K, Cremers CW, Feenstra L, Fryns JP. Acta Otorhinolaryngol Belg; 2001 Jun 01; 55(1):43-8. PubMed ID: 11256191 [Abstract] [Full Text] [Related]
13. Psychiatric inpatients and chromosome deletions within 22q11.2. Sugama S, Namihira T, Matsuoka R, Taira N, Eto Y, Maekawa K. J Neurol Neurosurg Psychiatry; 1999 Dec 01; 67(6):803-6. PubMed ID: 10567504 [Abstract] [Full Text] [Related]
15. Obsessive-compulsive disorder in patients with velocardiofacial (22q11 deletion) syndrome. Gothelf D, Presburger G, Zohar AH, Burg M, Nahmani A, Frydman M, Shohat M, Inbar D, Aviram-Goldring A, Yeshaya J, Steinberg T, Finkelstein Y, Frisch A, Weizman A, Apter A. Am J Med Genet B Neuropsychiatr Genet; 2004 Apr 01; 126B(1):99-105. PubMed ID: 15048657 [Abstract] [Full Text] [Related]
17. Analysis of speech characteristics in children with velocardiofacial syndrome (VCFS) and children with phenotypic overlap without VCFS. D'Antonio LL, Scherer NJ, Miller LL, Kalbfleisch JH, Bartley JA. Cleft Palate Craniofac J; 2001 Sep 01; 38(5):455-67. PubMed ID: 11522167 [Abstract] [Full Text] [Related]
18. Avoiding perils and pitfalls in velocardiofacial syndrome: an otolaryngologist's perspective. Cable BB, Mair EA. Ear Nose Throat J; 2003 Jan 01; 82(1):56-60. PubMed ID: 12610907 [Abstract] [Full Text] [Related]
19. Parental origin of the deletion 22q11.2 and brain development in velocardiofacial syndrome: a preliminary study. Eliez S, Antonarakis SE, Morris MA, Dahoun SP, Reiss AL. Arch Gen Psychiatry; 2001 Jan 01; 58(1):64-8. PubMed ID: 11146759 [Abstract] [Full Text] [Related]